SYNGENE

SYNGENE INTERNATIONAL

Large Cap BSE: 539268 NSE: SYNGENE
₹598.85
-1.7 (-0.28%)
As on 06 December, 2022 | 13:34

Syngene International Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SYNGENE INTERNATIONAL

Start SIP

Syngene International Share Price

Syngene International Share Returns

  • Over 1 Month -3.64%
  • Over 3 Month 3.54%
  • Over 6 Month 11.36%
  • Over 1 Year 0.71%

Syngene International Key Statistics

P/E Ratio 56.2
PEG Ratio 10.9
Market Cap Cr 24,040
Price to Book Ratio 7.3
EPS 10.4
Dividend 0.2
Relative Strength Index 47.96
Money Flow Index 32.51
MACD Signal 4.12
Average True Range 15.26

Syngene International Investment Rating

  • Master Rating:
  • Syngene Inter has an operating revenue of Rs. 2,812.10 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 89 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Syngene International Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 768645759640610594658
Operating Expenses Qtr Cr 552473509437432429443
Operating Profit Qtr Cr 216172249203177164215
Depreciation Qtr Cr 90868079767570
Interest Qtr Cr 12969187
Tax Qtr Cr 28193124151732
Net Profit Qtr Cr 102731471036777161

Syngene International Technicals

EMA & SMA

Current Price
598.85
-1.7 (-0.28%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 605.82
  • 50 Day
  • 597.16
  • 100 Day
  • 588.91
  • 200 Day
  • 584.38
  • 20 Day
  • 609.91
  • 50 Day
  • 590
  • 100 Day
  • 586.34
  • 200 Day
  • 579.12

Syngene International Resistance and Support

PIVOT
₹601.35
Resistance
First Resistance 604.71
Second Resistance 608.85
Third Resistance 612.21
RSI 47.96
MFI 32.51
MACD Single Line 4.12
MACD 1.68
Support
First Resistance 597.21
Second Resistance 593.85
Third Resistance 589.71

Syngene International Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 196,155 10,429,561 53.17
Week 334,458 15,829,888 47.33
1 Month 439,806 21,286,589 48.4
6 Month 784,782 41,004,864 52.25

Syngene International Result Highlights

Syngene International Synopsis

NSE-Medical-Research Eqp/Svc

Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 2601.40 Cr. and Equity Capital is Rs. 400.80 Cr. for the Year ended 31/03/2022. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
Market Cap 23,946
Sales 2,811
Shares in Float 14.05
No of funds 258
Yield 0.08
Book Value 7.31
U/D Vol ratio 1.1
LTDebt / Equity 16
Alpha
Beta 0.83

Syngene International

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 64.86%70.29%70.41%
Mutual Funds 4.78%2.79%3.26%
Insurance Companies 0.17%
Foreign Portfolio Investors 16.79%14.12%13.67%
Financial Institutions/ Banks 0.01%
Individual Investors 8.82%9.03%9.22%
Others 4.57%3.77%3.44%

Syngene International Management

Name Designation
Ms. Kiran Mazumdar Shaw Non Executive Chairman
Mr. Jonathan Hunt Managing Director & CEO
Prof. Catherine Rosenberg Non Executive Director
Ms. Vinita Bali Lead Independent Director
Dr. Vijay Kuchroo Independent Director
Dr. Carl Decicco Independent Director
Ms. Sharmila Abhay Karve Independent Director
Dr. Kush Parmar Independent Director
Mr. Paul Blackburn Independent Director

Syngene International Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Syngene International Corporate Action

Date Purpose Remarks
2022-10-19 Quarterly Results
2022-07-20 Quarterly Results
2022-04-27 Audited Results & Final Dividend
2022-01-19 Quarterly Results
2021-10-20 Quarterly Results
Date Purpose Remarks
2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 SPECIAL Rs.0.50 per share(5%)Special Dividend

Syngene International MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 26133
Kotak Equity Arbitrage Fund Growth 22082
ICICI Prudential Equity Arbitrage Fund Regular Growth 10891
ICICI Prudential Long Term Equity Fund (Tax Saving) Growth 10405
Nippon India Arbitrage Fund Growth 9008

Syngene International FAQs

What is Share Price of Syngene International ?

Syngene International share price is ₹598 As on 06 December, 2022 | 13:20

What is the Market Cap of Syngene International ?

The Market Cap of Syngene International is ₹24039.9 Cr As on 06 December, 2022 | 13:20

What is the P/E ratio of Syngene International ?

The P/E ratio of Syngene International is 56.2 As on 06 December, 2022 | 13:20

What is the PB ratio of Syngene International ?

The PB ratio of Syngene International is 7.3 As on 06 December, 2022 | 13:20

Q2FY23